ZOLL Medical Honored for Excellence in Customer Satisfaction for Ninth Consecutive Year

Company receives Omega NorthFace ScoreBoard Award for Technical Support and
Customer Service
CHELMSFORD, Mass.--(Business Wire)--
ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of medical devices and
related software solutions, announced today that it is one of only four
companies to receive the Omega NorthFace ScoreBoard AwardSM for the ninth
consecutive year for excellence in customer satisfaction. Now in its tenth year,
the award is presented annually by the Omega Management Group Corporation to
organizations that, as rated solely by their own customers, achieved excellence
in customer service and support during the prior calendar year.

ZOLL has qualified for the award nine times for its Technical Support, and was
also honored for a second consecutive year in the areas of Customer Service and
Shipping and Delivery. According to Omega, the awards in each category
"demonstrate an ongoing commitment to building profitable, long-term customer
loyalty by exceeding customer expectations."

"Since 2000, ZOLL`s customer satisfaction levels for technical support and
customer service have consistently remained high," said Jonathan A. Rennert,
President of ZOLL. "This type of consistency year after year clearly
demonstrates the importance we place on customer service as we develop products
that help advance the practices of resuscitation and critical care."

"Due to its unique `customer-only vote` criteria, the NorthFace ScoreBoard Award
has been viewed from its inception as the only objective benchmark for
excellence in customer service," said John Alexander Maraganis, President and
CEO of Omega. "In 2009, more than 200 projects, many international in scope,
were judged from 58 companies based in the U.S. and abroad. The majority of
companies are repeat recipients, which shows that, despite the tough economy,
implementing a Customer Experience Management strategy is a reliable, proven way
to achieve business success."

To qualify organizations for the award, Omega`s methodology measures customer
satisfaction and loyalty levels on a 5-point scale four times during the year.
NorthFace ScoreBoard Award recipients are companies who, based solely on survey
responses from their own customers, achieved a 4.0 or above out of a possible
5.0.

About Omega

Since 1984, the Omega Management Group Corp. has been a recognized expert in
developing and implementing customer and employee experience management strategy
(CEM) programs that lead to increased product and service revenue and profits.
Services include customer and employee surveys, employee incentive programs,
benchmark research and analysis, consulting, key account retention strategies,
win-back strategies; and marketing of customer satisfaction results to
stakeholders and the marketplace. For more information, visit
www.omegascoreboard.com.

About ZOLL Medical Corporation

ZOLL Medical Corporation develops and markets medical devices and software
solutions that help advance emergency care and save lives, while increasing
clinical and operational efficiencies. With products for defibrillation and
monitoring, circulation and CPR feedback, data management, fluid resuscitation,
and therapeutic temperature management, ZOLL provides a comprehensive set of
technologies that help clinicians, EMS and fire professionals, and lay rescuers
treat victims needing resuscitation and critical care.

A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company for the
past three years, ZOLL develops and manufactures its products in the United
States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and
Rhode Island. More than 400 direct sales and service representatives, 1,100
business partners, and 200 independent representatives serve our customers in
over 140 countries around the globe. For more information, visit www.zoll.com.

Certain statements contained in this press release, including statements
regarding the future business of the Company, and other statements contained
herein regarding matters that are not historical facts, are "forward-looking"
statements (as defined in the Private Securities Litigation Reform Act of 1995).
Because such statements are subject to risks and uncertainties, actual results
may differ materially from those expressed or implied by such forward-looking
statements. Factors that could cause actual results to differ materially from
those expressed or implied by such forward-looking statements include, but are
not limited to, those factors discussed in the section entitled "Risk Factors"
in the Company'sQuarterly Report on Form 10-Q filed with the SEC on February 11,
2010. You should not place undue reliance on the forward looking statements in
this press release, and the Company disavows any obligation to update or
supplement those statements in the event of any changes in the facts,
circumstances, or expectations that underlie those statements.

©2010 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford,
MA 01824-4105. ZOLL is a registered trademark of ZOLL Medical Corporation.
NorthFace ScoreBoard Award is a service mark of Omega Management Group
Corporation.

ZOLL Medical Corporation
INVESTOR CONTACT:
A. Ernest Whiton, +1 978-421-9655
Chief Financial Officer
or
MEDIA CONTACT:
Diane Egan, +1 978-421-9637
degan@zoll.com

Copyright Business Wire 2010